Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Cancer Therapy and Osteoporosis: Identifying Patients at High Risk for Skeletal Fractures

Diane Cope
CJON 2002, 6(2), 111-115 DOI: 10.1188/02.CJON.111

The purpose of this prospective, longitudinal study was to evaluate the effects of chemotherapy-induced ovarian failure on bone loss. The study sample included 64 premenopausal women diagnosed with stage I or II breast cancer receiving chemotherapy. Bone mineral density and biochemical indices of skeletal turnover were performed before chemotherapy and at six and 12 months postchemotherapy.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or